These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 19154729)

  • 1. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
    Cordes CM; Bennett RG; Siford GL; Hamel FG
    Biochem Pharmacol; 2009 Mar; 77(6):1064-73. PubMed ID: 19154729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin acts intracellularly on proteasomes through insulin-degrading enzyme.
    Duckworth WC; Bennett RG; Hamel FG
    Biochem Biophys Res Commun; 1998 Mar; 244(2):390-4. PubMed ID: 9514933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein.
    Farris W; Leissring MA; Hemming ML; Chang AY; Selkoe DJ
    Biochemistry; 2005 May; 44(17):6513-25. PubMed ID: 15850385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin degrading enzyme is localized predominantly at the cell surface of polarized and unpolarized human cerebrovascular endothelial cell cultures.
    Lynch JA; George AM; Eisenhauer PB; Conn K; Gao W; Carreras I; Wells JM; McKee A; Ullman MD; Fine RE
    J Neurosci Res; 2006 May; 83(7):1262-70. PubMed ID: 16511862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-degrading enzyme hydrolyzes ATP.
    Del Carmen Camberos M; Cresto JC
    Exp Biol Med (Maywood); 2007 Feb; 232(2):281-92. PubMed ID: 17259336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencing.
    Fawcett J; Permana PA; Levy JL; Duckworth WC
    Arch Biochem Biophys; 2007 Dec; 468(1):128-33. PubMed ID: 17964527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARgamma transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons.
    Du J; Zhang L; Liu S; Zhang C; Huang X; Li J; Zhao N; Wang Z
    Biochem Biophys Res Commun; 2009 Jun; 383(4):485-90. PubMed ID: 19383491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
    Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E
    Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
    Ciaccio C; Tundo GR; Grasso G; Spoto G; Marasco D; Ruvo M; Gioia M; Rizzarelli E; Coletta M
    J Mol Biol; 2009 Feb; 385(5):1556-67. PubMed ID: 19073193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoE 4 reduces the expression of Abeta degrading enzyme IDE by activating the NMDA receptor in hippocampal neurons.
    Du J; Chang J; Guo S; Zhang Q; Wang Z
    Neurosci Lett; 2009 Oct; 464(2):140-5. PubMed ID: 19616072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocapture-based fluorometric assay for the measurement of insulin-degrading enzyme activity in brain tissue homogenates.
    Miners JS; Kehoe PG; Love S
    J Neurosci Methods; 2008 Mar; 169(1):177-81. PubMed ID: 18221786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease.
    Zhao Z; Xiang Z; Haroutunian V; Buxbaum JD; Stetka B; Pasinetti GM
    Neurobiol Aging; 2007 Jun; 28(6):824-30. PubMed ID: 16769157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox regulation of insulin degradation by insulin-degrading enzyme.
    Cordes CM; Bennett RG; Siford GL; Hamel FG
    PLoS One; 2011 Mar; 6(3):e18138. PubMed ID: 21448434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between insulin-degrading enzyme activity and insulin sensitivity in cell model of insulin-resistance].
    Li CZ; Zhang SH; Shu CD; Ren W
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):151-4. PubMed ID: 12390813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-degrading enzyme antagonizes insulin-dependent tissue growth and Abeta-induced neurotoxicity in Drosophila.
    Tsuda M; Kobayashi T; Matsuo T; Aigaki T
    FEBS Lett; 2010 Jul; 584(13):2916-20. PubMed ID: 20493190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-degrading enzyme.
    Authier F; Posner BI; Bergeron JJ
    Clin Invest Med; 1996 Jun; 19(3):149-60. PubMed ID: 8724818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone inhibits insulin binding to insulin-degrading enzyme and cytosolic insulin-binding protein p82.
    Harada S; Smith RM; Hu DQ; Jarett L
    Biochem Biophys Res Commun; 1996 Jan; 218(1):154-8. PubMed ID: 8573122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nelfinavir on insulin metabolism, proteasome activity and protein degradation in HepG2 cells.
    Hamel FG; Fawcett J; Tsui BT; Bennett RG; Duckworth WC
    Diabetes Obes Metab; 2006 Nov; 8(6):661-8. PubMed ID: 17026490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proteolytic activity of insulin-degrading enzyme: a mass spectrometry study.
    Grasso G; Rizzarelli E; Spoto G
    J Mass Spectrom; 2009 May; 44(5):735-41. PubMed ID: 19127548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmitic acid and docosahexaenoic acid opposingly regulate the expression of insulin-degrading enzyme in neurons.
    Du J; Zhang L; Liu S; Wang Z
    Pharmazie; 2010 Mar; 65(3):231-2. PubMed ID: 20383947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.